CCES 2018 CCES vs Bettina Boucher

In March 2018 the Canadian Centre for Ethics in Sport (CCES) has reported an anti-doping rule violation against the Athlete after her sample tested positive for the prohibited substance Ephedrine.
After notification the Athlete gave a prompt admission, waived her right for a hearing, accepted the provisional suspension and the sanction proposed by CCES.

The CCES establishes that the Athlete’s degree of fault was moderate because the use of the substance was related to a medical condition for which she underwent treatment.
Therefore the CCES decides on 15 March 2018 to impose a 1 year period of ineligibility on the Athlete starting on the date after the last competition, i.e. backdated on 4 February 2018.

show »
Type:
pdf

Parameters:

Doping classes
S6. Stimulants
Laboratories
Montreal, Canada: Laboratoire de controle du dopage INRS-Institut Armand-Frappier
Legal
National decisions
Date:
27 March 2018
Arbitrator
Luke, Jeremy
Source
Canadian Centre for Ethics in Sport (CCES)
Country
Canada
Language
English
ADRV
Adverse Analytical Finding
Document type
pdf
Health/Medical
Legitimate Medical Treatment
IF'S
Athletics (IAAF) - International Association of Athletics Federations
Legal Terms
Acceptance of sanction
Commencement of ineligibility period
No intention to enhance performance
No Significant Fault or Negligence
Period of ineligibility
Prompt admission
Waiver of "right to be heard"
Organisations
Canadian Centre for Ethics in Sport (CCES)
Substances
Ephedrine
Category
  • (Medical) Science
  • Doping classes
  • Education
  • History
  • Laboratories
  • Legal
  • Statistics
Publication period
Origin
Country & language
  • Country
  • Language
Other filters
  • ADRV
  • Document category
  • Document type
  • Health/Medical
  • IF'S
  • Laboratories/Analysis
  • Legal Terms
  • Organisations
  • Substances
  • Various
  • Version